| Literature DB >> 33673331 |
Ryohei Saito-Moriya1,2,3, Jun Nakayama4, Genta Kamiya2,3, Nobuo Kitada2,3, Rika Obata2, Shojiro A Maki2,3, Hiroshi Aoyama1.
Abstract
Bioluminescence reactions are widely applied in optical in vivo imaging in the life science and medical fields. Such reactions produce light upon the oxidation of a luciferin (substrate) catalyzed by a luciferase (enzyme), and this bioluminescence enables the quantification of tumor cells and gene expression in animal models. Many researchers have developed single-color or multicolor bioluminescence systems based on artificial luciferin analogues and/or luciferase mutants, for application in vivo bioluminescence imaging (BLI). In the current review, we focus on the characteristics of firefly BLI technology and discuss the development of luciferin analogues for high-resolution in vivo BLI. In addition, we discuss the novel luciferin analogues TokeOni and seMpai, which show potential as high-sensitivity in vivo BLI reagents.Entities:
Keywords: bioluminescence imaging; high sensitivity; luciferase; luciferin analogue; multicolor; near-infrared light
Mesh:
Substances:
Year: 2021 PMID: 33673331 PMCID: PMC7918177 DOI: 10.3390/ijms22041848
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923